Developments in Reverse Merger Transactions: “Shell Company” Definition and New Constraints on Resales of Securities Acquired in Rule 145 Transactions
JD Supra: Mergers
JANUARY 22, 2024
The Staff of the Division of Corporation Finance at the Securities and Exchange Commission (SEC) has recently begun issuing comment letters in the life sciences reverse merger (RM) context that involve a broadened interpretation of the definition of “shell company" for the purposes of applicable SEC rules. By: Goodwin
Let's personalize your content